Avenue Therapeutics Inc (ATXI)

NASDAQ
0.273
+0.001(+0.00%)
After Hours
0.273
-0.001(-0.255%)
- Real-time Data
  • Volume:
    57,500
  • Day's Range:
    0.260 - 0.282
  • 52 wk Range:
    0.200 - 1.880

ATXI Overview

Prev. Close
0.273
Day's Range
0.26-0.282
Revenue
-
Open
0.282
52 wk Range
0.2-1.88
EPS
-0.3
Volume
57,500
Market Cap
6.05M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
262,259
P/E Ratio
-
Beta
1.02
1-Year Change
-84.47%
Shares Outstanding
22,134,784
Next Earnings Date
11 Aug 2022
What is your sentiment on Avenue Therapeutics?
or
Market is currently closed. Voting is open during market hours.

Avenue Therapeutics Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Avenue Therapeutics Inc Company Profile

Avenue Therapeutics Inc Company Profile

Employees
4

Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuyNeutralStrong Sell
Technical IndicatorsBuyBuyStrong BuySellStrong Sell
SummaryStrong BuyStrong BuyStrong BuyNeutralStrong Sell